On January 2, 2019 Forbius, a clinical-stage company developing biologics for the treatment of fibrosis and cancer, reported that Ilia Tikhomirov, CEO of Forbius will be presenting at the 37thAnnual J.P. Morgan Healthcare Conference (Press release, Forbius, JAN 2, 2019, View Source [SID1234532332]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Tikhomirov’s presentation will take place Wednesday, January 9th at 11:30 a.m. PST in Elizabethan D at the Westin St. Francis Hotel in San Francisco.